Technical analysis of Quantum BioPharma Ltd. (QNTM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.
Price Performance
| 1 month | +9.28% |
| 3 months | -3.95% |
| Year-to-date | -50.00% |
| 1 year | -79.46% |
| 3 years | -96.49% |
| 5 years | -96.38% |
52-Week Range
| 52-week High | $21.00 |
| 52-week Low | $2.07 |
| Avg Volume (90d) | 258K |
Technical Indicators
| SMA 50 | $3.24 |
| SMA 200 | $4.77 |
| Beta | 0.29 |
| 30-day Volatility (annualised) | 94.9% |
| Price vs SMA 50 | +12.7% |
| Price vs SMA 200 | -23.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|---|---|
| 2025-10 | $11.07 | |
| 2025-11 | $9.70 | -12.4% |
| 2025-12 | $7.30 | -24.7% |
| 2026-01 | $4.58 | -37.3% |
| 2026-02 | $3.55 | -22.5% |
| 2026-03 | $4.83 | +36.1% |
| 2026-04 | $5.73 | +18.6% |
| 2026-05 | $6.86 | +19.7% |
| 2026-06 | $3.62 | -47.2% |
| 2026-07 | $2.89 | -20.2% |
| 2026-08 | $3.17 | +9.7% |
| 2026-09 | $3.65 | +15.1% |
Price
| Price | $3.65 |
| Market Cap | $23M |
| Exchange | NASDAQ |
| Country | CA |
Financial Health
| Piotroski F-Score | 1 |
| Altman Z-Score | -26.98 |
Related companies: ANVS · ATNM · BCAB · CELU · CPIX · EVAX · PYPD
Explore sector: Healthcare · Biotechnology
More sections of QNTM: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks